Maintaining business continuity during COVID-19

Lessons learned will have positive impacts beyond the pandemic

December 17, 2020 · Cell Sourcing, COVID-19, Industry Updates, Supply Chain

A roundup of COVID-19 treatments in development

How COVID-19 is accelerating cell therapy innovation

December 3, 2020 · COVID-19, Emerging Science, Industry Updates

Being an NMDP/Be The Match courier during COVID-19

Making essential treatments possible in the midst of a pandemic

September 25, 2020 · COVID-19, Supply Chain

Overcoming autologous cell therapy logistics challenges in the age of COVID-19

Experienced team for managed logistics is key

June 9, 2020 · Cell Sourcing, COVID-19, Industry Updates, Q&A, Supply Chain

Can cell therapies unlock the COVID-19 mystery?

The promise of MSC therapies to treat deadly manifestations of cytokine storms

May 29, 2020 · COVID-19, Emerging Science, Industry Updates

How COVID-19 is changing the production of cell therapies

Implementation of contingency plans allows for continued progress in therapy development

May 21, 2020 · Cell Sourcing, COVID-19, Industry Updates, Supply Chain

Managing donor collections during the COVID-19 pandemic

Why a diverse apheresis center network is critical to business continuity

April 10, 2020 · Cell Sourcing, COVID-19, Q&A, Supply Chain

Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)

Why established systems and relationships matter

February 20, 2020 · COVID-19, Industry Updates, Q&A, Supply Chain